Skip to main content

Table 2 Association between TET1 expression and clinical characteristics in NPC tissues

From: TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells

Characteristics

Number (n = 33)

TET1 expression

p value

None

Low

Moderate

High

Age (years)

 48

16

2

9

4

1

0.778

 < 48

17

1

8

6

2

Gender

 Female

9

0

4

4

1

0.548

 Male

24

3

13

6

2

WHO histological type

 I (keratinizing)

5

0

2

3

0

0.401

 II/III (non-keratinizing)

28

3

15

7

3

Clinical stages

 I

6

1

4

1

0

0.255

 II

13

1

8

4

0

 III

12

1

5

3

3

 IV

2

0

0

2

0

Lymph node metastasis

 positive

21

1

9

8

3

0.179

 negative

12

2

8

2

0